SEARCH

SEARCH BY CITATION

Reference

  • 1
    Rodnan GP: Progressive systemic sclerosis (scleroderma), Arthritis and Allied Conditions. Ninth edition. Edited by DJMcCarty. Philadelphia, Lea &Febiger, 1979, pp 762809
  • 2
    D'Angelo WA, Fries JF, Masi AT, Shulman LE: Pathologic observations in systemic sclerosis (scleroderma). Am J Med 46: 428440, 1969
  • 3
    Weaver AL, Divertie MB, Titus JL: Pulmonary scleroderma. Chest 54: 490498, 1968
  • 4
    LeRoy EC: Scleroderma (systemic sclerosis), Textbook of Rheumatology. Edited by WNKelley, ED HarrisJr, SRuddy, CBSledge. Philadelphia, WB Saunders, 1981, pp 12111230
  • 5
    Rodnan GP, Black RL, Bollet AJ, Bunim JJ: Observations on the use of prednisone in patients with progressive systemic sclerosis (diffuse scleroderma). Ann Intern Med 44: 1629, 1956
  • 6
    Alarcón-Segovia D, Ramos-Niembro F, Ibanez de Kasep G, Alcocer J, Perez Tamayo R: Long-term evaluation of colchicine in the treatment of scleroderma. J Rheumatol 6: 705712, 1979
  • 7
    Ceglia UH: Behandlung der idiopatisch fibrosierenden Alveolitis. Schweiz Med Wochenschr 107: 184187, 1977
  • 8
    Schulz G: Die Behandlung diffuser Lungenfibrosen mit D-Penizillamin. Z Gesamte Inn Med 33: 7782, 1978
  • 9
    Goodman M, Knight RK, Turner-Warwick M: Pilot study of penicillamine therapy in steroid failure patients with interstitial lung disease, Modulation of Autoimmunity and Disease. Edited by RNMaini, HBerry. Eastbourne, UK, Praeger, 1981, pp 291300
  • 10
    Kang B, Veres-Thorner C, Heredia R, Cha E, Bose S, Schwartz M: Successful treatment of far-advanced progressive systemic sclerosis by D-penicillamine. J Allergy Clin Immunol 69: 279305, 1982
  • 11
    Bröll H, Tausch G, Eberl R: Zur Behandlung der Interstitiellen Lungenfibrose mit D-Penicillamin bei progressiver Sklerodermie (Langzeitstudie). Wien Klin Wochenschr 88: 292295, 1976
  • 12
    Dequeker J, Francx L, Mbuyi JM: Effect of long-term D-penicillamine, corticosteroid and no treatment on lung diffusion capacity in progressive systemic sclerosis, Modulation of Autoimmunity and Disease. Edited by RNMaini, HBerry. Eastbourne, UK, Praeger, 1981, pp 283290
  • 13
    Smiley JD, Johnson RL Jr, Ziff M: Effect of D-penicillamine on pulmonary function in patients with progressive systemic sclerosis (abstract). Arthritis Rheum 10: 313314, 1967
  • 14
    Turner-Warwick M: Approaches to therapy. Semin Respir Med 6: 92102, 1984
  • 15
    Medsger TA Jr: Progressive systemic sclerosis. Clin Rheum Dis 9: 655670, 1983
  • 16
    Wilson RJ, Rodnan GP, Robin ED: An early pulmonary physiologic abnormality in progressive systemic sclerosis (diffuse scleroderma). Am J Med 36: 361369, 1964
  • 17
    Black LF, Katz S: Respiratory Disease: Task Force Report on Problems, Research Approaches, Needs. DHEW publication no. NIH 77–1248, National Heart and Lung Institute, 1977
  • 18
    Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23: 581590, 1980
  • 19
    Sharp GC, Irvin WS, Tan EM, Gould PJ, Holman HR: Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52: 148159, 1972
  • 20
    Ogilvie CM, Forster RE, Blakemore WS, Morton JW: A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest 36: 117, 1957
  • 21
    Cotes JE: Lung Function. Fourth edition. Oxford, Blackwell Scientific Publications, 1979, p 246
  • 22
    Quanjer PH: Standardised lung function testing. Bull Eur Physiopathol Respir 19: 195, 1983
  • 23
    Welch BL: The significance of the difference between two means when the population variances are unequal. Biometrica 29: 350, 1938
  • 24
    Eisenberg H: The interstitial lung disease associated with the collagen-vascular disorders. Clin Chest Med 3: 565578, 1982
  • 25
    Spain MD, Thomas AG: The pulmonary manifestations of scleroderma: an anatomic-physiologic correlation. Ann Intern Med 32: 152161, 1950
  • 26
    Nimni ME: Penicillamine and collagen metabolism. Scand J Rheumatol 8: 7178, 1979
  • 27
    Uitto J, Helin P, Rasmussen O, Lorenzen L: Skin collagen in patients with scleroderma, biosynthesis and maturation in vitro, and the effect of D-penicillamine. Ann Clin Res 2: 228234, 1970
  • 28
    Schumacher K: Grundlagen der immunosuppressiven Wirkung von D-Penicillamin. Internist (Berlin) 16: 450465, 1975
  • 29
    Jaffe IA: Penicillamine treatment of rheumatoid arthritis: effect on immune complexes. Ann NY Acad Sci 256: 330337, 1975
  • 30
    Lipsky PE, Ziff M: Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO2. J Clin Invest 65: 10691076, 1980
  • 31
    Lengfelder E, Fuchs C, Yonnes M, Weser U: Functional aspects of the superoxide dismutative action of Cu-penicillamine. Biochim Biophys Acta 567: 492502, 1979
  • 32
    Johnson KJ, Fantome, JC III, Kaplan J, Ward PA: In vivo damage of rat lungs by oxygen metabolites. J Clin Invest 67: 983993, 1980
  • 33
    Cegla UH, Meier-Sydow J, Kroidl R, Kronenberg H: Hoch-dosierte D-Penicillamin Therapie (3.6 g/die) bei Lungen fibrosen. Pneumologie 250: 261269, 1974
  • 34
    Colp CR, Rike J, Williams MH: Serial changes in scleroderma and idiopathic interstitial lung disease. Arch Intern Med 132: 506515, 1973
  • 35
    Lorber A: Rheumatoid lung disease treated successfully with D-penicillamine (case report) (abstract). Arthritis Rheum 8: 454, 1965
  • 36
    Meier-Sydow J, Rust M, Kronenbergh H, Thiel CL, Arnther M, Riemann H: Longterm follow-up of lung function parameters in patients with idiopathic pulmonary fibrosis treated with prednisone and azathioprine or D-penicillamine. Prax Klin Pneumol 33: 680688, 1979
  • 37
    Turner-Warwick M: Future possibilities of therapeutic intervention, Lung Cells in Disease. Edited by ABouhuys. Amsterdam, Elsevier North Holland, 1976, pp 329340
  • 38
    Asboe-Hansen G: Treatment of generalized scleroderma with D-penicillamine and other inhibitors of collagen synthesis, Penicillamine Research in Rheumatoid Disease. Edited by EMunthe. Oslo, Fabritius &Sonner, 1976, pp 284289
  • 39
    Jayson MIV, Black CM, Lovell CR, Bailey AJ: The effect of D-penicillamine on collagen in systemic sclerosis and rheumatoid arthritis, Penicillamine Research in Rheumatoid Disease. Edited by EMunthe. Oslo, Fabritius &Sonner, 1976, pp 105109
  • 40
    Thomson J, Milne JA: Two years of penicillamine for progressive systemic sclerosis: a case report. Postgrad Med J 5: 3638, 1974
  • 41
    De Muth GR, Furstenberg NA, Dabich L, Zarafonetis CJD: Pulmonary manifestations of progressive systemic sclerosis. Am J Med Sci 255: 94104, 1968
  • 42
    König G, Luderschmidt C, Clocuh YP, Scherer U, Fruhmann G: Klinische Bedeuting der broncho-alveolären Lavage bei progressiver systemischer Sklero-dermie. Dtsch Med Wochenschr 107: 723727, 1982
  • 43
    König G, Luderschmidt C, Hammer C, AdelmannGrill BC, Braun-Falco O, Fruhmann G: Lung involvement in scleroderma. Chest 85: 318324, 1984
  • 44
    Silver RM, Metcalf JF, Stanley JH, LeRoy EC: Interstitial lung disease in scleroderma: analysis by broncho-alveolar lavage. Arthritis Rheum 27: 12541262, 1984
  • 45
    Taormina VJ, Miller WT, Gefter WB, Epstein DM: Progressive systemic sclerosis subgroups: variable pulmonary features. AJR 137: 277285, 1981
  • 46
    LeRoy EC, Maricq HR, Kahaleh MB: Undifferentiated connective tissue syndromes. Arthritis Rheum 23: 341343, 1980
  • 47
    Martens J, Demedts M, Vanmeenen MT, Dequeker J: Respiratory muscle dysfunction in systemic lupus erythematosus. Chest 84: 170175, 1983
  • 48
    Hunninghake GW, Fauci AS: Pulmonary involvement in the collagen vascular diseases: state of the art. Am Rev Respir Dis 79: 471523, 1979
  • 49
    Catterall M, Rowell NR: Respiratory function in progressive systemic sclerosis. Thorax 18: 1015, 1963
  • 50
    Owens GR, Fino GJ, Herbert DL, Steen VD, Medsger, TA Jr, Pennock BE, Cottrell JJ, Rodnan GP, Rogers RM: Pulmonary function in progressive systemic sclerosis: comparison of CREST syndrome variant with diffuse scleroderma. Chest 84: 546550, 1983